RCM
CORZW

Radcliffe Capital Management’s Core Scientific, Inc. Warrant CORZW Stock Holding History

Radcliffe Capital Management’s Portfolio CORZW Stock Details CORZW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-31,250
Closed -$307K – 972
2021
Q2 		$307K Buy
+31,250
New +$37.3K 0.01% 882

Other funds holding CORZW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Radcliffe Capital Management's CORZW Position: Q3 2021 in Review

Radcliffe Capital Management sold out of Core Scientific, Inc. Warrant (CORZW) in Q3 2021, closing a stake of 31,250 shares — an estimated $307K sold.

Radcliffe Capital Management first reported a position in CORZW in Q2 2021 and held it in 1 quarter. The position peaked at $307K in Q2 2021. 39 funds tracked by Wall St. Rank hold CORZW as of Q3 2021.

  • Radcliffe Capital Management reported no remaining Core Scientific, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 31,250 Core Scientific, Inc. Warrant shares in Q3 2021, an estimated $307K.
  • Radcliffe Capital Management first reported a position in Core Scientific, Inc. Warrant in Q2 2021 and held it in 1 quarter.
  • Radcliffe Capital Management's Core Scientific, Inc. Warrant position peaked at $307K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Core Scientific, Inc. Warrant as of Q3 2021.

Based on Radcliffe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.